Impact of COVID-19 pandemic on SLE: beyond the risk of infection

Lupus Sci Med. 2020 May;7(1):e000408. doi: 10.1136/lupus-2020-000408.
No abstract available

Keywords: antirheumatic agents; interferon type I; lupus erythematosus, systemic.

Publication types

  • Letter

MeSH terms

  • Betacoronavirus / isolation & purification
  • COVID-19
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / prevention & control*
  • Coronavirus Infections / virology
  • Humans
  • Lupus Erythematosus, Systemic / diagnosis*
  • Lupus Erythematosus, Systemic / drug therapy*
  • Pandemics / prevention & control*
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / prevention & control*
  • Pneumonia, Viral / virology
  • SARS-CoV-2